Physician profile
Eva C Larocque
NPI 1346271061
$1,745.82
in general payments reported to CMS, 2019-2025
10 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $497 · 2020: $185 · 2021: $391 · 2022: $387 · 2023: $83.54 · 2024: $29.39 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $185 · Education: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $185.03 |
| Education | $101.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $521.47 | 2019-2025 | Austedo Xr, Uzedy |
| Janssen Pharmaceuticals, INC | $305.66 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $198.99 | 2019-2025 | Abilify Asimtufii, Rexulti |
| Neurocrine Biosciences, INC. | $177.27 | 2019-2024 | Ingrezza |
| Allergan, INC. | $159.71 | 2019 | |
| Alkermes, INC. | $133.60 | 2019-2023 | Aristada, Lybalvi |
| Abbvie INC. | $120.96 | 2021-2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $52.31 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $52.30 | 2020-2021 | |
| Lundbeck LLC | $23.55 | 2019-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eva Larocque listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.